Skip to search formSkip to main contentSkip to account menu

4-hydroxyatomoxetine

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2005
Review
2005
Atomoxetine (Strattera®), a potent and selective inhibitor of the presynaptic norepinephrine transporter, is used clinically for… 
Review
2004
Review
2004
UNLABELLED Atomoxetine (Strattera) is a selective norepinephrine reuptake inhibitor and nonstimulant that has shown greater… 
Highly Cited
2003
Highly Cited
2003
The role of the polymorphic cytochrome p450 2D6 (CYP2D6) in the pharmacokinetics of atomoxetine hydrochloride [(-)-N-methyl-gamma… 
Highly Cited
2003
Highly Cited
2003
Atomoxetine is a treatment for attention‐deficit/hyperactivity disorder and is primarily eliminated via cytochrome P4502D6… 
Highly Cited
2003
Highly Cited
2003
OBJECTIVE Atomoxetine is indicated for the treatment of attention deficit hyperactivity disorder in children, adolescents, and… 
Highly Cited
2002
Highly Cited
2002
Studies were performed to determine the human enzymes responsible for the biotransformation of atomoxetine to its major… 
Highly Cited
2002
Highly Cited
2002
The purpose of this study was to characterize the effect of potent CYP2D6 inhibition by paroxetine on atomoxetine disposition in…